, The Green Pennies Stock Report: August 2017

Pages

Wednesday, August 16, 2017

Renewable Energy and Power, Inc. (RBNW) Forward-Looking Analysis

Print Friendly and PDF

Business Information:

Renewable Energy and Power, Inc.
Ticker: RBNW
PPS: 0.0705 a/o 8/16/2017
Up 0.0526 or (+293.85%)

Market Value: $6,117,275 a/o August 15, 2017
Authorized Shares: 750,000,000 a/o April 26, 2017
Outstanding Shares: 86,769,860 a/o August 08, 2017

#111 3395 Cheyenne Ave
N. Las Vegas, NV 89032
Phone Number: 1(702)685-9524

Fundamental Analysis:

According to Renewable Energy and Powers’ website, RBNW is dedicated to a cleaner, greener planet. They provide the best alternatives to traditional and fossil fuel power through our commitment to solar energy and LED lighting. RBNW strives to reduce their collective carbon footprint, so our environment is safe, renewable, and cost efficient. They are in the business of generating and cultivating emerging technology in renewable energy, producing effective and reliable energy, and power solutions to consumers and corporations worldwide.

RBNW has LEDLItes USA, Sol-HY, and Power Stac as their main product lines. LEDLites USA are green energy solutions that provide their customers greater product functionality and superior cost-benefits for their LED Lighting. Their second product line, Sol-HY, uses Tandem Solar Cells that provide twice the solar energy conversion to electricity as compared to standard silicon solar cells. These patented processes increase solar cell output, interconnect reliability, provide their electrical efficiency and significant production cost savings while conserving expensive semiconductor materials. Finally, Power Stac offers Green Energy storage by employing proprietary new technologies in Re-Dox Battery Energy Storage Systems.

Renewable Energy and Powers’ Management:

Mr. Donald M. Macintyre, Chairman, Chief Executive Officer (CEO), and President
Bruce Parsons, Chief Financial Officer (CFO), Treasurer, and Director
Mr. Bruce Macintyre, Vice President of Marketing, Secretary, and Director
Mr. Perry Barker, Vice President of Sales and Director

Statistics:

Market Cap (Intraday): 2.12M
Trailing P/E: -0.02
Price/Sales: 2.92
52-Week Change: -95.53%
52-Week High: 0.80
52-Week Low: 0.00009
50-Day Moving Average: 0.1350
200-Day Moving Average: 0.3033
Average Volume (3 Month): 655.27k
Average Volume (10 Day): 3.83m

Quarterly Report Published on May 25, 2017:

First, let’s look at the condensed balance sheet for Renewable Energy and Power, Inc. We see that the company has $1,302,176 in total assets, $1,831,230 in total liabilities, ($529,054) in total shareholders’ deficit, and $1,302,176 in total liabilities and shareholders’ deficit.

Next, let’s look at the condensed statements of operations (income statement). Looking solely at the numbers for the three month period ending on March 31, 2017, we see that the company has $203,052 in revenue. The cost of revenue is at $176,405, thus making the gross profit $26,647. Now we factor in the operating expenses with total expenses being $98,439, leaving RBNW with an operating loss of ($71,792). RBNW also had ($6,364,895) in other expenses, leaving the company with a net loss of ($6,436,687).

P.S. Note that this is the Quarterly Report for March. We could not find the Quarterly Report for the quarter ending in June as it has not likely come out.

Market Analysis:

From the International Energy Agency, they expect that global power generation from renewable energy sources will rise to over 26% of the market by 2020 from 22% in 2013. They also report that renewable energy costs have declined in many parts of the world due to sustained technology progress, improved financing conditions, and expansion of deployment to newer markets with better resources. Due to these circumstances, Renewable Energy and Power, Inc. is in a good position to pull through with their cheap and power efficient line of products.

News:

On August 1, 2017, Marketwired reported that Renewable Energy and Power, Inc. is in the process of improving the functionality and designing customized housing for a variety of LED lights to be submitted for possible use in the new Raiders football stadium to be constructed in downtown Las Vegas.
On July 6, 2017, Marketwired reported that RBNW announced that after completing their evaluation, a large San Francisco Bay Area electronic assembly corporation has approved the installation of 1,275 LED lights for their entire main campus.

On June 14, 2017, Marketwired reported that RBNW announced it has contracted with a large contract electronic assembly corporation in the San Francisco Bay area to retrofit with LED lighting both the indoor and outdoor facilities of the corporation’s main campus.

On June 7, 2017, Marketwired reported that RBNW announced that it has contracted with an LED lighting Installation Company to supply the latest LED lighting for the first facility of a large dining franchise, located in an extended shopping complex that is also considering switching to LED lighting.

Technical Analysis:

In a timescale of 3 years, RBNW has spent most of its time between the 0.005 and 0.0001 region with some significant spikes along the way. The stock exploded on 2/6/17 from a pps (price per share) of ~0.003 to 0.4502 on 4/3/17. The stock stayed around this level until it fell from 0.4587 on 5/15/17, to 0.2943 on 5/29/17. Again, it stayed near this price until it fell again from 0.3153 on 7/3/17 to a bottom of 0.0119 on 7/24/17. From this price, the stock gradually is climbing to this day to a price of 0.0705.

Looking at resistance lines (a price where the stock has trouble pushing above/below), we see 0.3111 being the next point of resistance. From here, 0.4629 will likely be the next point of resistance. On the downside,  the lower resistance line is at 0.0076. The current Bollinger Bands show a range between 0.0001 and 0.6246. Current RSI (or Relative Strength Index) is at 38.0126 or oversold. Also, I see that selling volume is overtaking buying volume currently.

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. On 8/15/2017, RBNW was rated on the breakout board as it was receiving an enormous amount of exposure from the massive price gain today. Many different people are discussing the stock on the board. Twenty Nine people have RBNW added to their “My Stocks” tab. Currently, the community sentiment is bullish. We would rate this all as a plus for the stock!

Forward-Looking Analysis:

There’s no doubt that RBNW had a great day today with its +293.85% increase in pps. That leaves the question of how should investors play the stock now? It is evident from the news articles that the company is bringing in much new business that will help with the ~$6,000,000 loss from the last quarter. If RBNW was able to turn this positive, the company could be on its way to breaking $1 as the o/s (outstanding shares) is pretty light currently with 86,769,860 shares. If this turns out not to be the case, then the company will likely pay that amount down thus making this a great long term opportunity. From a short term strategy, it is tough to say if I would be a good idea to buy in. On the one hand, you have the “What goes up must come down mindset” kicking in saying that this sharp spike will likely correct. On the contrary, it is possible that this could continue to run thus making this an excellent opportunity to “Ride the Wave.” What do you think? I would love to hear your opinions in the comments section below!

Disclosure:

I wrote this article myself, and it expresses my own opinion. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

P.S.


Be sure to subscribe if you liked the material! We analyze many stocks just like these to help you find new and exciting stocks. Also, let’s discuss this article (and this stock) in the comments section below. Thanks for reading!
Print Friendly and PDF

Fundamental Analysis And How To Make It Work For You (Part 2)

Print Friendly and PDF

Richard L. Musgrave
8/16/2017

The Importance of News
Another part of fundamental analysis is looking through both the companies news releases as well as watching regional, national, or global news sources. For example, say that there is a new law that’s just passed that will affect the company negatively. As investors, we don’t take the negative news lightly at all. In fact, negative news will likely cause a rush towards the exit door with tons of selling. If you were on your game and caught the poor news being released, you have a much better chance of saving your money. On the contrary, if you missed the news, you might be stuck inside of a sinking stock. You might not be able to find anyone to buy your shares so you can exit the stock. This could cycle to badly that you might lose most of your money. Keeping track of the news is a worthwhile and easy precaution that’ll help you protect your money in the long run.

How to use Fundamental Analysis Effectively

Now that you’ve learned how to conduct fundamental analysis on a company, it’s time that you find out how to integrate it into your trading strategy. When many people first start, they tend to ignore the financial statements released by these companies. I find the act of ignoring critical financial information to be a grave mistake.

For example, I had a friend that look purely at how the lines were trending and totally ignored fundamental analysis. He bought in with his buy-in capital and the next thing he knew, it dropped. There were two reasons to this. First off, the company was taking a huge loss and was getting crippled under all of its debt. Its response to this was to dilute their shares into the market. Needless to say, my friend provided an exit for these scrambling investors to bail the stock. The second reason (and the more compelling/sad reason) was that my friend was only looking at the daily stock charts and ignoring the monthly or three-month stock charts. If he had used these other time scales, he would’ve seen that the stock was in a sharp decline. With a lot of luck, I was able to help him pull out his money without a loss.


Seriously, fundamental analysis is completely full of very important information. By not looking into it, you put yourself at a huge disadvantage. Some people think of the stock market as gambling, and it only is if you don’t try to understand it. I’m trying to teach you how to use the available data in such a way to win more often than not.

Richard L. Musgrave
8/16/2017
Print Friendly and PDF

Fundamental Analysis And How To Make It Work For You (Part 1)

Print Friendly and PDF

Fundamental Analysis

To have the best chance making money in the stock market, it’s only natural that you’d want to know all the details of the company before you actually buy into the stock. This is where fundamental analysis comes from. Fundamental Analysis is doing research into the company that you’re buying stock in. This means that you’ll go to either the NASDAQ or the OTCMarkets perspective websites and look through the company’s financial statements. As I talked about above, you’ll have to find the companies filings and look through their quarterly and annual reports.

Consolidated Balance Sheet

Looking through these filings, you’ll see a lot of financial data that you can use to your advantage. The first data table that you’ll see is the consolidated balance sheet. The first thing being discussed in this table is the companies assets. Assets include things like the companies cash on hand, any money that is currently owed to them (accounts receivable), the value of their current inventory, prepaid expenses, and much more. You can think of assets as the financial value of all the companies property.

Next, we have the companies liabilities. In my time learning accounting in college, I’ve come to think of liabilities as debt. In the Current Liabilities Column, we might find things like accounts payable (debt that needs to be paid), deferred rent payable, note payable, unearned revenue, derivative liability, and maybe a few others.

After this, we see the Commitments and Contingencies / Stockholder (Deficit) Equity Column. Here, we see the amount of restricted shares that have been sold by the company as well as the total stockholders’ (deficit) equity. Restricted shares are shares that are sold by the company but have special rules attached to them. For example, you might come across things like Series A Restricted Stock. Restricted stock tends to have an amount of time that the stock has to be held before the stock can be sold into the market. It’s also worth noting that the value of 1 restricted stock might be equal to many normal stocks. Let's say that you gained 50 shares of restricted stock. The restricted shares would likely have a time limit that you’d have to wait before you could sell them. Also, when you do actually sell them, 1 restricted share could be turned into 100 normal shares. Therefore, you’d have 5000 shares by the time you could sell them. There’s a lot of rules and many different types of restricted shares and is certainly an interesting read to further your understanding of investing.

Consolidated Statements of Operations

This table holds (in my opinion) the most important financial information about the company. My biggest question for the company is, “Is the company profitable?”. Naturally, many investors would feel more secure about buying shares from a company when the company is making money in the first place. There’s a quick discussion I want to have with you real quick before we want to read the following information from this table.

First off, accounts use () or parenthesis to dictate a negative number. For example, if the company took a loss in overall operations, the amount they lost would be in (). For example, (51,000) is a negative number.

Also, many people who are learning about accounting tend to misinterpret two very important terms, revenue and profit. The reason I bring this up is because I’ve know people who thought they knew the difference and ended up getting burned pretty bad for it. Revenue is the amount of money the company makes from its sales or services. This is where the company is actually getting paid for their goods and services. But what about the money you lost for creating, marketing, or doing the service. The cost of sales is how much it costs to get the goods sold in the first place.

Revenue
-Cost of Sales
=Gross Profit

Gross Profit is the margin (or the difference) that the company actually made money on. The opposite of this is a Gross loss (or sometimes the gross deficit).
With this being said, we forget about a few other expenses that the company will need to cover. After all, running a business means paying for rent, employees, and new equipment. These are described in the administrative expenses column.
Moving downward, you’ll see the income (loss) from operations.  This is simply the amount of money left over after other business expenses have been taken out.  From here, we leave a space for any other sources of income as well as expenses that the company has recorded. Examples of this would be a change in fair value of derivative liability, gain(loss) on debt, interest income, and interest expenses. Once we’ve covered this, we’re left with a final number that will either be the company showing a profit or a loss.

*Sometimes numbers might be dictated by, x1000 meaning that you take the listed numbers and multiply them by 1000. It’s basic table reading, but it can be easily missed so be sure to keep an eye out.

Revenue
-Cost of Sales
=Gross Profit
-Administrative Expenses
+Other Income (Expenses)
= Net Income (Loss)  <- Profit or Deficit

Consolidated Statement of Stockholders’ (Deficit) Equity

In this table, we see the number of shares outstanding in the company, the number of restricted shares sold by the company, the price with which those shares were sold, and the Stockholders (Deficit) Equity. This is important to use because this will tell you about any dilution that might be occurring. Plus, you can use the total stockholders (Deficit) Equity column to see how the final balance in cash is spread between all of the companies shares. After all, owning a part of the company means that you own a part of the assets.

Consolidated Statements of Cash Flows

In this table, we see how the company has spent their cash on hand over the course of the quarter. The first thing worth noting is how the tables compare the cash on hand from this quarter to that of the year prior. As an investor, use this added information to see how the company has grown over time. Has the company had an increase in overall profits and has increased their cash on hand? Maybe the company continues to pile on more and more debt and prolonging their eventual bankruptcy.  Mainly, this table allows us to see how the company is tending to their financial obligations.

Notes to the Consolidated Financial Statements


Once you get to this part of the filing, you’re pretty much done with tables. The many pages that follow break down, talk about, and describe the tables that you saw above. Also,  you’ll see useful information such as a description of what the company does to make money (as talked about in the Organization & Nature of Operations paragraph), information about their fiscal year, and the companies forward-looking thoughts. I personally like looking at the companies forward-looking thoughts as it talks about whether the company has adequate money to continue business or whether there is a doubt that the company will be able to survive normal operations.  I advise that you read through most (if not all) of the information here to just to get a feel for how all of the data in the tables above are meant to be used. 

By: Richard L. Musgrave
8/16/2017
Print Friendly and PDF

Monday, August 14, 2017

Progressive Care, Inc. (RXMD) 2nd Quarterly Report Analysis

Print Friendly and PDF


Business Information:

Progressive Care, Inc.
Ticker: RXMD
PPS: 0.0179 a/o 8/14/2017
Up 0.0006 or +3.47%

2nd Quarterly Report:

First, let’s start off with Progressive Cares’ consolidated balance sheet (unaudited). RXMD has $514,925 in cash, $1,127,160 in accounts receivable (trade, net), $120 in accounts receivable (other), $406,350 in inventory (net), $56,730 in prepaid expenses, $316,834 in property and equipment (net), and $25,746 in total other assets (deposits). This gives Progressive Care a total of $2,447,865 for their total assets.

Next, we have Progressive Cares’ liabilities. RXMD has $1,410,832 in accounts payable and accrued liabilities, $85,107 in deferred rent liability, $298,081 in notes payable (net of unamortized debt discount and debt issuance costs), $17,836 in capital lease obligations (current portion), $186,130 in unearned revenue, and $7,840 in derivative liability. This gives RXMD a total of $2,005,826 in total current liabilities. Next, we see that RXMD has a long-term liability in the amount of $106,022 for capital lease obligations (net of current portion), thus giving RXMD $2,111,848 in total liabilities. RXMD has a total stockholders’ equity of $336,017 and a total liabilities and stock holders’ equity of $2,447,865.

Finally, let’s look at Progressive Cares’ consolidated statements of income (income statement; unaudited). For the three month period ending on June 30, 2017, we see that RXMD made $5,173,064 in their net sales. RXMD then had $ 3,877,551 for their cost of sales, giving RXMD a gross profit of $1,295,513.

$5,173,064          100%       (Sales, Net)
($3,877,551)   ~-74.957%  (Cost of Sales)
=$1,295,513    ~25.043%   (Gross Profit)

Next, we have RXMD’s selling, general, and administrative expenses. RXMD has $8,484 in bad debt expenses, and $1,412,600 in other selling, general, and administrative expenses. This gives RXMD a (Loss) income from operations amounting in ($125,571).

$1,295,513      ~25.043%     (Gross Profit)
-($1,421,084)    ~-27.471%    (Other selling, general, and administrative expenses; Taken from net sales)
=($125,571)       ~-102.427% (Loss from operations; Taken from net sales)

RXMD then has an additional loss from total other income (expenses) in the amount of ($12,979). This gives RXMD a net loss of ($138,550).

=($125,571)       ~-102.427% (Loss from operations)
-($12,979)          ~0.2509%     (Total other income(expenses, net)
=($138,550)       ~-102.678% (Net Loss)

Analysis:

We would like to focus mainly on the income statement for our analysis. These are the numbers we created for the 1st Quarterly Report…

$4,847,663
($3,268,703)                            ~67.43% in Cost of sales
($1,402,247)                            ~28.93% in Admin Expenses
($13,049)                                 ~0.2692 in Other Expenses
$163,664 Net Profit               ~3.376% of left over revenue

Now let’s compare the numbers from the 2nd Quarterly Report.

$5,173,064          100%       (Sales, Net)
($3,877,551)      ~-74.957%  (Cost of Sales)
-($1,421,084)    ~-27.471%    (Other selling, general, and administrative expenses; Taken from net sales)
-($12,979)          ~0.2509%     (Total other expenses, net)
=($138,550)       ~-102.678% (Net Loss)

Looking at this comparison, the cost of sales has grown %7.527, and Administration Expenses has decreased by 1.459%. This is alarming as this has put RXMD back into the negatives concerning profit.

The major question is, “What is the cause for the %7.527 increase in the cost of sales?”
Did the cost of materials to create their products go up?
Is RXMD spending more to sell their products?

Either way, RXMD needs to resolve this as they obviously can’t continue to run at a loss.

Disclosures:

I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

Invest Responsibly


If you have anything that you would like to add to this article, please write it in the comments section below. Be sure to give me a like and subscribe if you like the article! Thanks!!!
Print Friendly and PDF

Sunday, August 13, 2017

Michael James Enterprises, Inc. (MJTV) Forward-Looking Analysis

Print Friendly and PDF


Business Information:

Michael James Enterprises, Inc.
Ticker: MJTV
PPS: 0.001762 a/o 8/13/2017
Up 0.00076 or +76.20%

Market Value: $41,296 a/o August 11, 2017
Authorized Shares: 980,000,000 a/o June 06, 2017
Outstanding Shares: 23,463,424 a/o June 06, 2017
Float: 15,000,000 a/o June 06, 2017

760 Route 10 West
Suite 203
Whippany, NJ 07981

Phone: (908) 204-0004

Fundamental Analysis:

According to OTCMarkets, Michael James Enterprises, Inc. identifies and engages in the development and marketing of consumer products. They are developing six essential oils and other ingredients. The primary product will be VOLUPTAS and is expected to be introduced into the market by the end of 2017 as a female sexual arousal booster. On August 4, 2016, Michael James Enterprises, Inc. also acquired the exclusive rights to the science for the treatment of sleep Apnea utilizing Dronabinal with one other active ingredient.

Michael James Enterprises, Inc.’s Management:

Mr. James M. Farinella, Chairman, Chief Executive Officer  & CFO
Ms. Gina Morreale, COO  & Director
Ryan Summers, Creative Director

Statistics:

Market Cap (Intraday): 41.34K
Beta: 5.76
52-Week Change: -99.00%
52-Week High: 0.18
52-Week Low: 0.001
50-Day Moving Average: 0.001997
200-Day Moving Average: 0.009871
Average Volume (3 Month): 290.47k
Average Volume (10 Day): 487.23k

Market Analysis:

According to Grand View Research, the U.S. essential oil market size was valued at $3.36 billion in 2015 and is expected to witness an estimated growth rate of 9.0% from 2016 to 2024. Around 200 different types of essential oils are consumed all over the world annually, and the U.S. plays a significant role in overall demand. Increasing consumer disposable incomes and rapid expansion of food and beverage industries are expected to contribute to the demand for natural fragrances and flavors produced.

News:

MJTV looks to be very busy with many articles being released between 12/10/15 and 3/28/17. Interestingly though, we were not able to find any news past the date of 3/28/17.

On 12/15/16, Michael James Enterprises is pleased to report that the company has begun to generate revenue with the release of its first product LUNA. As a proof of concept and market test, MJTV bottled 50 units of LUNA and offered it for sale at a promotional price of $19.95. All 50 bottles sold out within three days with numerous requests for more of the LUNA product.

On 12/22/16, Michael James Enterprises, Inc. reduced their Outstanding Shares by over 40% retiring 9,000,000 Shares from outstanding of 21,659,603 to 12,659,603.

On 1/17/17, Michael James Enterprises, Inc. is pleased to report that it has eliminated more than $1,000,000 of debt and liabilities with the spinoff of BullsNBears Holdings, Inc. on December 27, 2016.

On 2/8/2017, Michael James enterprises, Inc. is extremely pleased to report that as promised on December 22, 2016, CEO, James M. Farinella last week retired 8,425,000 shares. This retiring of shares had the effect of reducing the outstanding number of shares from 25,029,572 down to 16,604,572, a 33.6% reduction.

On 3/9/17, Michael James Enterprises, Inc. is extremely pleased to report that approximately two weeks ago it filed for patent protection for VOLUPTAS.

On 3/13/17, Michael James Enterprises, Inc. is happy to report that it has entered into a design and development agreement with Glove Medical Tech, Inc. of Houston, Texas for the revolutionary female sexual booster VOLUPTAS.

On 3/20/17, Michael James enterprises, Inc. more than doubled the number of units of LUNA sold in the first quarter of 2017.

On 3/22/17, Michael James Enterprises, Inc. is pleased to report that the company has developed two more essential oil alchemy products and is in the final test marketing for the both products. This will bring MJTV essential oil product line to 3 with an additional two more essential oil mixtures to come shortly bringing the total to 5.

On 3/28/17, Michael James Enterprises, Inc. launches, “What is a Beautiful Woman” branding and marketing campaign in advance of the VOLUPTAS market launch.

Filings and Disclosures:

Looking at the 10-Q from June 14, 2017, we first see Michael James Enterprises, Inc.’s’ balance sheets (unaudited). We see that the company has $7,070 in cash and $1,000 for accounts receivable for March 31, 2017. Total Current Liabilities for the company are $1,054,958. Total stockholders’ Equity is at (1,046,888), and total liabilities and stockholders’ equity (DEFICIT) is at $8,070.

Now looking at the consolidated statements of operations (unaudited), we see that the company has no revenue. The company has accumulated $5,669,646 for their total operating expenses. They had a loss of $157,476 for their total other Income (Expenses), bringing their net loss to (5,827,122).

On July 10, 2017, the company released an 8-K stating that on June 27, 2017, Raj Pamnani and James Farinella are resigning from their positions as directors and officers of the company. On June 28, 2017, the company, by written direction of the sole Director, appointed as a Director of the Company Maxine Pierson which was accepted by Ms. Pierson. Ms. Pierson was also elected as Chief Executive Officer. The change of the officers and directors became effective as of July 1, 2017.

On July 31, 2017, the company released an 8-k stating that on July 26, 2017, MJ BIOTECH, INC., entered into a “Binding Letter of Agreement” for the acquisition of Zen Hero, Inc. d/b/a Zen’s Tea House, ZEN HERO business is a formulator of Organic Teas for sale to the public and other businesses. The transaction is anticipated to close within ninety (90) days. The proposed purchase price is a combination of cash ($750,000) and stocks. $400,000 is payable on closing with the balance to be paid based on performance milestones.

Technical Analysis:

In a timescale of 3 years, MJTV spiked up to a three year high of 1.40 on 8/17/15. This later ended up falling to 0.4987 on 9/21/15 and then falling down to 0.1902 on 1/25/16. It saw the last spike up to 0.6375 on 3/7/16 and then fell to 0.071 by 10/3/16. The stock continued to fall until it hit a low of 0.001 on 7/25/17. The current RSI (or Relative Strength Index) is at 45.5029 though it stays around 38.7035. The stock seems to have consolidated around the region of 0.0039 and 0.001. The high resistance line to break currently is at 0.0044, with the next being at 0.0089.

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. The last post to the IHUB board was made eight days from the time of this articles writing. There looks to be only 3-5 people posting to the board. Seven investors have MJTV added to their “My Stocks” tab. Community Sentiment seems to be somewhat bullish though it is not completely free of bearish sentiment. The lack of activity on this board can be seen as a negative.

Forward-Looking Analysis:

Our team has decided that the best way to play this stock would be to be patient and to wait for more information from the company. If you have already bought into the company at a high, it might be worth waiting to see if you could regain some lost ground over time. If you have bought it at a low before this current PPS, it might be worth selling because of the “What Comes Up Must Come Down Strategy.” Due to the high increase in the stock price very recently, it is likely that the stock might try to correct itself in time. We would not advise trying to get into a short strategy currently. A long approach might come into play if the company releases new news in regards to ongoing sales. It is clear with the recent 8-K's that the company is going through some changes so it would be wise to keep an eye on that as well.

Disclosures:

I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.

Invest Responsibly

If you have anything that you would like to add to this article, please write it in the comments section below. Be sure to give me a like and subscribe if you like the article! Thanks!!!
Print Friendly and PDF

MediaG3, Inc. (MDGC) Forward-Looking Analysis

Print Friendly and PDF


Business Information:

MediaG3, Inc.
Ticker: MDGC
PPS: 0.0011 a/o 8/13/2017
Up 0.0005 or (+83.33%)

1501 South Federal Way
Boise, Idaho 83705
United States
208-321-4188

Market Value: $1,642,860 a/o August 11, 2017
Authorized Shares: 1,500,000,000 a/o June 30, 2013
Outstanding Shares: 1,493,509,343 a/o June 30, 2013
Float: 1,190,769,673 a/o June 30, 2013

Fundamental Analysis:

According to Reuters, MediaG3, Inc. is engaged in the designing, developing, and deploying of wireless broadband internet, wireless networks, fixed and mobile internet, communications, media, and entertainment products and services for individuals and companies of all sizes. The company’s products include broadband wireless access base stations and customer premises equipment for fixed and mobile point-to-point digital microwave radio systems for internet access.

MediaG3 Management:

Dr. Robert P. McNamara Ph.D., Technology Advisor
Mr. Steven Keating, Financial Advisor
Mr. Val Westergard, Chairman, and Chief Technology Officer
Byron Ryals, Vice Chairman, and Chief Executive Officer

Statistics:

Market Cap (Intraday) 1.65M
Trailing P/E: -1.10
Beta: -169.88
52-Week High: 0.0011
52-Week Low: 0.00006
50-Day Moving Average: 0.0005
200-Day Moving Average: 0.0002
Average Volume (3 Month): 6.33M
Average Volume (10 Day): 31.88M

On August 9, 2017, news broke titled, “International Venture Society Presents the Following Shareholder Updates (OTC PINK: GRDO, MSMY, MDGC).” International Venture Society has been in talks with the court about creating a state charter revival, company reconstruction plan, and to find possible merger candidates as well as to get these companies to meet regulatory compliance.

“I am hopeful that the stockholders of the individual companies will view the courts' decision as a vital first step for International Venture Society to construct these long non-operational OTC companies into legitimate businesses once again,” stated International Venture Society CEO Kelani Long. 

NO CURRENT OTCMARKETS FILINGS!

Technical Analysis:

In a timescale of 3 years, MDGC has bottomed out between the regions of 0.0002 and 0.00005. There was a spike on 9/5/16 that gave the stock a three year high of 0.001, though this went back down to 0.0001 on 9/12/16. What is very interesting is that since the above news article broke, the stock has taken off, reaching its new high of 0.0011 with an increase of 83.33%. Volume shows that there is a tremendous amount of buy volume, 364.129 million from 7/31/2017 to 8/7/2017. The current RSI (or Relative Strength Index) is at 77.2867 or very overbought. It is clear that there is tons of interest here. The big question would then be, if the O/S (or outstanding shares) is at 1.5 billion, how high will this stock jump grow. The 1 Million Dollar question is, “Is there an even larger move to be seen here?”

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. Looking through the board, it is apparent that news from International Venture Society stirred up some interest here. Before the news article, there were very few posts. Now that the news has hit though, the forum has been fairly busy with many faces discussing their future with the company. Eighty-Two investors have this stock listed under their “My Stocks” list. The Community Sentiment for the stock is also overwhelmingly positive.

Forward-Looking Analysis:

From my experience as an investor, my answer would have to be, “What goes up must come down.” My reasoning behind this is due to the 1.5 billion shares. It is great that there’s interest in another company merging (or at least taking over the company), but I doubt the company will be injected with enough funds to add actual value to all of those shares. That is not to say that it will not happen, it is just that as investors, we should keep a skeptical mind. I suggest being patient and hear what International Venture Society brings forth as their plan. If the plan is solid, then this would turn into a buying opportunity. Anything else from that would have to be up to your decision as an investor (as many possible scenarios could play out).

This stock might be worth while trying to short if this spike on the news continues to run. I cannot gauge where the company might hit upward resistance lines as this company has not seen these levels in price in years.

If you were interested in establishing a long position here, I would suggest maybe putting in ½ or ¼ of your money in (this is purely our opinion; invest responsibly), and wait until International Venture Society shows their plans to reform the company. If these programs meet your expectations, then you would have the confidence to green light your decision to buy more shares. Otherwise, if the news from IVS is underwhelming, then you will have an easier time pulling out if need be.

Disclosure:

This is our opinions on how to play the stock. Be responsible and do your own research to find your own best personal strategy. Also, message me if there’s any more information that would be worth adding to the article in the comment section below.

I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.



Additional disclosure: I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting. I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.
Print Friendly and PDF

Saturday, August 12, 2017

MC Endeavors, Inc. (MSMY) Forward-Looking Report

Print Friendly and PDF

Business Information:

MC Endeavors, Inc.
Ticker Symbol: MSMY
PPS: 0.0013 a/o 8/12/17
Up 0.0006 or %85.71

According to Reuters, MC Endeavors is a global smart-home builder and self-sustaining community developer of natural disaster resistant building systems that utilize steel framing or steel shipping containers with rigid closed-cell foam insulation instead of conventional wood framing and rolled fiberglass. 

Company Management:

Mr. Timothy L. Algier, Chief Executive Officer (CEO), President and Director
Mr. Joshua Graham, Chief Operating Officer (COO) and Director
Ricki Groetzmeier, Sec., Treasurer and Director
Israel Sanchez, Director of Design Devel

Statistics:

Price/Sales: 2.13
Beta: -3.22
52-Week Change: 133.33%
52-Week High: 0.0015
52-Week Low: 0.0002
50-Day Moving Average: 0.0007
200-Day Moving Average: 0.0007
Average Volume (3 Months): 596.53k
Average Volume (10 Day): 3.1M
Shares Outstanding: 238.88M
Float: Unknown

NO OTC Filing (DANGER)
NO SEC FILINGS
NO PINK NO. FILINGS

NO RECENT NEW ARTICLES

Technical Analysis:

In a timescale of years, the stock has been slowly increasing its pps (or price per share) from its two year low of 0.0001 on April 26, 2016, to its two year high of 0.0013 on 8/12/17. Between this period, the pps has been fairly volatile, moving between the 0.0004 region to the 0.0010 region. This seems to be the average range for the pps to fall between this time scale.  

Social Analysis:
For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. MSMY has a somewhat active board on IHUB with about 5-7 people posting about the stock. Also, there are 56 people that have this stock added to their "My Stocks" tab. The community sentiment is fairly bullish as well. This community is a plus for investors looking to find value in this company.

Forward-Looking Analysis:

First, the fact that the company is not filing to OTCMarkets nor releasing any news is a huge red flag. Investors beware.

Purely looking for a technical analysis standpoint, the fact that the pps is going up ever so slightly is nice to see. The only thing though is that the stock on many occasions does still test the 0.0003 region a lot (though it has been happening less and less frequently with the last instance hitting 0.003 on May 1st, 2017).

You could attempt to short the stock, buying low at 0.003 and flipping high near the 0.10 range, but because the stock is not filing any reports, investors should be wary of this stock. Also, volume seems to be pretty light so if you did decide to jump in, it is highly suggested that you see if the volume you buy in at is small enough that you can get out without trouble.

Disclosure:

This is our opinions on how to play the stock. Be responsible and do your own research to find your own best personal strategy. Also, message me if there’s any more information that would be worth adding to the article in the comment section below.

I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.


Additional disclosure: I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting. I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.
Print Friendly and PDF

Jupiter Marine International Holdings Inc. (JMIH) Forward-Looking Analysis

Print Friendly and PDF

Business Information:

Jupiter Marine International Holdings Inc.
Ticker: JMIH
PPS: 0.0057  a/o 8/12/2017
Up 0.0027 or +89.70%

Market Value: $107,335 a/o August 11, 2017
Authorized Shares: Data Not Available
Outstanding Shares: 18,863,861 a/o Oct 20, 2006

Fundamental Analysis:

According to Reuters, Jupiter Marine International Holdings, Inc. (JMIH) is engaged in building offshore sport fishing boats. The company is focused on boat designing and development. The company’s manufacturing plant is located in the gulf coast of Florida. The company claims that it has many makes and models of boats to choose.

Jupiter Marines’ Management:

Mr. Carl M. Herndon Sr. CEO, Pres, Director, CEO of JMI, Pres of JMI and Director of JMI
Mr. Lawrence S. Tierney, Chief Operating Officer (COO), Chief Financial Officer (CFO), Vice President, Secretary, and Director

Statistics:

Price/Sales: 0.01
Beta: 10.45
52-Week High: 0.005691
52-Week Low: 0.003
50-Day Moving Average: 0.003
200-Day Moving Average: 0.003

NO SEC FILINGS
NO PINK NO. FILINGS

NO RECENT NEW ARTICLES

Technical Analysis:

In a timescale of 3 years, JMIH has consolidated in price as time went on. JMIH hit a three year high of 0.015 on 10/6/14 and a three year low of 0.003 on 12/12/16. This stock has seen many bounces between 0.003 and the 0.01 region over the course of these three years. In fact, the Bollinger Bands have constricted on this range. The RSI (or Relative Strength Index) sits at 49.5578 which is neither overbought nor oversold. Volume has not been overwhelmingly positive nor negative in this time range either. Looking at volatility, it looks like the company slowly tests these resistance lines (the 0.003 and 0.01 region). Each test takes between two to six months to occur.

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. We were able to find a board with a total of 15 posts overall with the last post being eight months ago. There isn’t much social activity on these stock which is a sign that there is not investing interest here.

Forward-Looking Analysis:

Our team has decided that the best way to play this stock would be to have a position as a short. By on a clear low of ~0.003 and sell at ~0.01. If done successfully, this could net you a nice ROI. From here, you could play on the house if you wanted, or to continue trying to flip the stock for further ROI. Make sure that you buy enough stock that you could sell in the first place though. With very little interest, you might accidentally put yourself into a position that you cannot get out of. If you are interested in doing this, I would suggest doing your research beforehand and make sure that you will be able to sell your shares when the time comes.

We would not suggest a long position in this stock unless new news becomes available from the public.

Lastly, because there is no news on how the company is doing financially, this stock holds the possibility of dissipating, so invest very carefully here.


This is our opinions on how to play the stock. Be responsible and do your own research to find your own best personal strategy. Also, message me if there’s any more information that would be worth adding to the article in the comment section below.

Disclosure:

I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.


Additional disclosure: I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting. I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.
Print Friendly and PDF

Papa Bello Enterprises, Inc. (PAPA) Forward-Looking Analysis

Print Friendly and PDF

Business Information:
Papa Bello Enterprises, Inc.
Ticker: PAPA
PPS: 0.0048  a/o  8/11/2017
Up 0.0023 or +92.00%

Market Value: $497,190 a/o August 11, 2017
Authorized Shares 200,000,000 a/o June 27, 2012
Outstanding Shares: 103,581,341 a/o Jun 30, 2012
Float: 32,841,420 a/o June 27, 2012

Fundamental Analysis:

According to OTCMarkets, Papa Bello Enterprises (PAPA) owns and operates a diversified group of companies as majority owned subsidiaries. Papa also provides expansion tools and operational support services to growth-stage businesses. This includes branding, manufacturing, financing, distribution, as well as other business related planning aids.

Mr. Merle Ferguson Chairman, Chief Executive Officer (CEO) and President
Mr. Frank Pastore, Chief Operating Officer (COO) and Director of Franchise Sales and Training
Mr. Lawrence Feierstein, Vice President of Sales and Marketing
Mr. Sunit Saha, President of Papa Bello Pizza
Ms. Judy Schuler, Controller of Papa Bello Enterprises Inc. – Nevada

Beta: -3.88
52-Week High: 0.0049
52-Week Low: 0.0015
50-Day Moving Average: 0.0022
200-Day Moving Average: 0.0020
Average Volume (3 Months): 266.23k
Average Volume (10 Day): 189.12k

NO SEC FILINGS
NO PINK NO FILINGS

NO RECENT NEW ARTICLES

Technical Analysis:

Looking at a time scale of 3 years, we see that the stock jumped from a relative low of 0.0025 on 11/17/14 to a new high of 0.0299 on 3/9/15. From this date, we see that the stock declined downward until it hit a new relative low of 0.0048 on 8/3/15. From here, the stock quickly spiked (likely from news) to a relative high of 0.0229 on 10/19/15. After this spike, the stock continued its fall downward to a relative low of 0.0015 on 6/26/17. From this date, we see a positive climb to the present day. No news or press release can explain this new climb except for a very positive amount of volume starting back in 10/3/16 to the present day. The RSI (or Relative Strength Index) is sitting at 65.97, or overbought.

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. Looking on IHUB, there aren’t that many people posting. Also, there are significant gaps in between people posting as well. While the sentiment of the stock seems to be overall bullish, there has been some lightly bearish sentiment making its way into the stock, likely because of the overbought RSI rating. Eleven people have this stock marked under their “My Stocks” tab.

Forward Looking Analysis:

The first and most important thing that we want to address is the fact that there is a lack of news or press releases from the company. To many investors, this is a huge warning signal and serves as a huge doubt the company able to continue normal operations, or that they are barely just scraping through.

Now looking at the company from a purely technical analysis stand point, it is very interesting to see such a high influx of positive volume. With the RSI being so overbought, it is clear that someone is accumulating a lot of stock. It 's hard to comprehend why we would see this kind of buying without getting into a land of pure speculation.

It is also worth noting that the pps (or price per share) of the company is relatively cheap compared to the volatile fluctuations over the last year. Of course, if these fluctuations were to continue into the future, this would signal a possible buying opportunity. Without any communication with the company, this would be a significant risk for an investor to partake in.

Our suggestion if you are looking into playing this stock might be to hold or sell depending on your situation. If you bought in at the low of 0.0015, we would suggest maybe taking the money that you put into the stock out and “play on the house” or solely with the money you have made from your gains. If you bought in high compared to the current pps, then you could either sell while the pps is rather relatively high, or hold to see if this high amount of volume continues. Lastly, with the high amount of volume that we are seeing, it makes me wonder if someone is trying to buy the company through the stock. This merger might be worth keeping an eye on as if news is released that a company is trying to buy the company completely, your shares might be worth much more than the current pps. I would again advise a hold (and watch) strategy with this scenario.



This is our opinions on how to play the stock. Be responsible and do your own research to find your own best personal strategy. Also, message me if there’s any more information that would be worth adding to the article in the comment section below.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Additional disclosure: I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting. I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.
Print Friendly and PDF

Friday, August 11, 2017

What's Up With The Marijuana Stock News Spam - Vaping Bad Investing Experience - Nevada?

Print Friendly and PDF

I woke up earlier today with SeekingAlpha and IHUB spamming my phone with spam like "Why Marijuana is a must buy" and "Marijuana is great for investors!" First off, I want to get one thing straight. I live in Montana where it is still illegal to use or/and have Marijuana. I personally don't condemn anyone who uses it because I honestly don't care if you use it or not, as long as you're not a distraction. I don't want to be walking around the part with some creep blowing the awful smell everywhere. I'm totally okay if you do it as long as you are respectful about it. Oh, and it's illegal in Montana so I should tell you not to do it, though it seems like everyone does anyway. 

Getting back to the subject at hand though, I don't know why marijuana stocks are trying to take over the OTC with aggressive marketing. Honestly, it's still against the federal law meaning that your business (unless licensed by the federal government) is illegal! As an investor, I don't want to be playing that kind of game with the feds. Plus, there's the risk of having my money sitting there astray. 

Lastly, on this specific topic, I wanted to talk about how safe it is to actually invest in these companies. I'm not talking about the federal government in this specific case. I'm talking about these businesses themselves. Sure, they're licensed on the state level, but how harsh are they while regulating. Let me reword that actually. How much are these states letting these businesses get away with? Sure, there are some reputable ones out there, but I still wouldn't feel safe about throwing my money at something that still has an illegal and underground stigma attached to it. If this trade was regulated better, then this stigma would slowly go away, but not until things are tightened down for investors. I think these advertisement campaigns are trying to change the stigma and I don't think it's helping.  

___________________

Not too long ago, I ended up buying into two different Vaping Companies. I would also like to note that both of these companies were based out of Nevada. The one company took all of the money from the business, and ran off to China because of a merger, and left the shareholders completely dry. It was kind of like a pump and dump scheme, except that all investors were screwed. The SEC was contacted and to this day, the people affected by that insanity are still fighting it. I was lucky because I ended up taking my money out literally the week before that insanity started to go down. 

About a month and a half after that, I ended up finding another Vaping Company that seemed a lot more promising. Its price was right and there was a pretty good following on the stocks forum. I ended buying a really good sized position into the company. Literally the day after, the company released news that it was being bought out by another company for x millions of dollars and that money would be distributed to investors. I ended up selling at a high because I needed to make some personal money at the time and I'm very happy I did. Two months would pass without any PR's or anything. I was watching from the peanut gallery to see if maybe there was another chance for me to buy in. What ended up happening was that the business that bought the company was an LLC and (I believe) the company was added on as a partner to the LLC in such a way that the investors wouldn't get anything out of it. To this day, investors still haven't heard anything from the company. Of course, the SEC was contacted again, and lord knows what they're currently doing about it. 

My question is, both of these businesses were based out of the safe State. Does Nevada have relaxed laws that let businesses do more shady stuff than the rest? I have nothing personal against Nevada but it really does make me wonder what happened with all that. All those investors lost tons of money and I honestly feel bad for them. Heck, that could have been me sitting out there defeated. OUCH!



This is just a random little talking blog that I'm doing where I just speak what's off the top of my head. If you'd like me to continue, message me or like the content. :) Thanks!!!
Print Friendly and PDF

Progressive Care, Inc. Forward-Looking Analysis

Print Friendly and PDF

Business Information:

Progressive Care, Inc.
Ticker: RXMD
901 North Miami Beach Boulevard Suite 1, 2
North Miami Beach, FL 33162
1-786-657-2060

PPS: 0.01907 a/o 8/10/17
Up 0.00177 or (10.23%)

Market Value: $6,589,545 a/o Aug 10, 2017
Authorized Shares: 500,000,000 a/o May 15, 2017
Outstanding Shares: 345,545,107 a/o May 15, 2017
Float: 313,793,000 a/o May 15, 2017

Fundamental Analysis:

According to Progressive Cares’ website, Progressive Care, Inc. is a South Florida health services organization and provider of administration and practice management, utilization management, quality assurance, HER Implementation, billing and coding, health practice risk management, prescription pharmaceuticals, the sale of anti-retroviral medications, compounded medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. Progressive Care is also the owner of PharmCo LLC.

Progressive Care, Inc., through the years, has added a number of services and business lines including custom compounded medications, medication, therapy management (MTM), 340B services to charitable organizations, health practice risk management, and in-home health risk reviews. They are also moving forward in expanding the company across the nation, as well as acquiring other pharmacies, and further developing new revenue streams for their current market.

Progressive Care. Inc. Management
Shital Mars, Chief Executive Officer (CEO)
Alan Jay Weisberg, Chief Financial Officer (CFO) & Chairman


Shareholders on Record: 18 a/o May 15, 2017
Short Interest 71,046 (58.48%)

Trailing P/E: -1.19
Price/Sales: 0.05
Price/Book: 0.54
Beta: -26.28
Average Volume (3 Months): 395.27k
Average Volume (10 Day): 533.56k

52-Week Change -45.94%
52-Week High: 0.03800
52-Week Low: 0.01300
50-Day Moving Average: 0.01820
200-Day Moving Average: 0.02104

Source: Yahoo Finance -

There is much competition for Progressive Care. Inc. to fight against in the over-the-counter market as well as the at home medical care market. The biggest of these competitors are Walgreens and Rite Aid as they are a permanent national healthcare establishment. Progressive Care to counter is getting the licensing to do business in all 48 states of America. The global market for over-the-counter (OTC) drugs are valued at $133.25 Billion and is expected to climb up to $220 Billion by 2021.

Looking at Progressive Cares’ income statement (1st Quarter of 2017), the net sales were at $4,847,663. The costs of sales were at $3,268,703 leaving us with a gross profit of $1,578,960. The gross profit is ~32.57% of the revenue gained by the cost of sales being ~67.43% of revenue. Progressive Care also accumulated $1,402,247 in expenses from selling, general, and administrative expenses. This mixed with other income (expenses) leaves up with the net income (profit) of $163,664. The profit is achieved with a thin margin of 3.376% being left from the net sales.

$4,847,663
($3,268,703) ~67.43% in Cost of sales
($1,402,247) ~28.93% in Admin Expenses
($13,049) Other Expenses
$163,664 Net Profit ~3.376% of left over revenue




Progressive Cares’ balance sheet statement (1st Quarter of 2017) shows that Progressive Care had $788,179 in on-hand cash. Total current assets for the company are at $2,581,113. RXMD has $1,995,156 in total current liabilities, $111,390 in long-term liabilities, and $2,106,546 in total liabilities. Total Liabilities for Shareholders is currently at $2,581,113.

Note: This information comes directly from the 1st Quarterly Report of 2017. You can think of liabilities like credit card debt with intent to pay.

On July 14, 2017, Progressive Care sent out a press release holding information on the Second Quarterly Report. RXMD announced $1.7 million in net revenues in June 2017. They noted that they filled nearly 19,000 prescriptions showing off a 3% increase in the same quarter last year. They also pointed out that the company is currently restructuring Smart Medical Alliance to adjust to the changes in the ever changing healthcare environment. This includes securing new management for the company and the research and implementation of new programs to provide custom solutions for healthcare practitioners. Using the above percentages from the last quarterly press release, RXMD would end up with $57,392 in net revenue (profit).

On June 8, 2017, Progressive Care issued a press release stating that PharmCo has filled nearly 36,000 prescriptions and realized revenue of over $3.3 million during the April and May. This represents an 18% increase in revenue over the same period last year. They also stated that they are participating in a “Full Enterprise Best Practices Evaluation.” They noted that they are searching for new talent to become members of the Board of Directors as well as senior management.

Technical Analysis:

In a timescale of 2 years, RXMD has suffered from it fall free its three year high of ~0.0506 pps. Since then, the stock has been stuck in a period of consolidation. This period of consolidation began around 8/1/16 and ended up breaking downward on 1/23/17 to a now average pps of 0.0210. Looking at recent charts (6 months – 3 months) it is clear that the stock has been testing the lower resistance line and adding more negative pressure for the stock. With it is rebounding right now, there has been no testing of the upper Bollinger bands of the stock suggesting that there might be a move downward soon. Using resistance lines, it is suggested that the next significant point of resistance (if a break was to occur downward) would put the pps at 0.014. Following this, the next resistance line would be at 0.008.

The future of the stock, in our opinion, relies on whether the company can pay down the ~$2 million it has in liabilities. As of right now, it seems that the company has enough money to slowly pay down these liabilities. This debt clearly is hindering the company thus making it more difficult for the company to grow organically. The opposite is true in that if they were able to get the liabilites down, the company would have much more room to grow. Sales are increasing quarter after quarter which is very promising for long term investors. On the short term though, I would advise caution. While the current price movement could be considered volatile (such that you could flip and make a profit), because of the possibility of the lower resistance line breaking, you could get put in a bad situation.

Social Analysis:

For social analysis, we look at what investors are posting about the stock on sites like IHUB and Yahoo Money. RXMD historically has had a very active community based around the stock with many of the same longs still holding. I see this as a sign of health and good will for the stock. It is worth noting that bashers are trashing the companies’ name, though this is to be expected with flippers trying to make money. While this is not an ideal situation for investors posting on the board, I still see this as a sign of health.

There are people on there trying to defend the stock quoting its financial profit. I agree that this is something to be proud of, though I [personally] feel that the company should invest into finding out how to bring the cost of sales down. The company loses ~68% of the money it makes to cost of sales. If this number could be negotiated down, the company would organically increase the number of profits every month. This would cause the company to feel more comfortable to investors as the company is still relatively close to their breakeven point. If the market was to change and RXMD got unlucky, it is possible that RXMD could slip back into the negative earnings. Plus, they could focus the money on added labor, research and development, and paying down the liabilities.

Lastly, the board does have a somewhat negative sentiment lingering (though the longs are trying to fight it off). The fact is, the price per share has been slowly sinking for a while now. The company is awaiting news on mergers, acquisitions, or any other news that might make the price jump.

Forward-Looking Analysis:

Our team has decided that the best way to play this stock would be to hold if you have shares, possibly sell on a high for a profit if possible. Keep an eye on the news as well as the fundamentals. If things improve, the price per share will reflect it. Lastly, be careful. Our stock patterns suggest a move downward from this period of consolidation (due to the repeated attempts to break the resistance line). If this line breaks, you might put yourself at a loss in the short term. RXMD is a great company that is doing great things. May they continue to help their local community and may their future business practices bring rewards.

Disclosure:

I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. I also will not be holding shares in the company in the next two weeks of this articles posting.

I have no positions in any stocks mentioned and have no plans to initiate any positions within the next 72 hours.


Trade Responsibly
Print Friendly and PDF